All Insights
Are European advertising laws ready for patient support programmes?
Trade secrets remain the sticking point in global debate over a vaccine IP waiver
Hemp tea - the fine line between food and narcotics
The first article from our series "Cannabis - the 'green gold' from a legal perspective"
Debate intensifies over a vaccine IP waiver's impact on future pharma and biotech discoveries
Does a proposed patent suspension backed by Washington open a Pandora's box for vaccine R&D and investment?
Queen's Speech 2021 sets out ambitious agenda for UK life sciences and healthcare
New parliamentary term will be packed with legislation for life sciences and healthcare businesses
Patents Court upholds validity of second medical use patent for glaucoma treatment
This decision shows the court assessing patentability in a real-world practical context, recognising the uncertainties of R&D that only later
Support programmes offer global healthcare ways to meet patients' needs
With technological advances increasing access to patient support programmes, what legal and regulatory issues do pharmaceutical companies need to take
UK government backs breakthrough tech with £375m future fund
Successor to a coronavirus support scheme as well as a new sovereign investment partnership offer crucial access to capital for
Would a global vaccine IP waiver stifle future biopharma breakthroughs?
Pressure for an IP rights waiver to fight the pandemic threatens vaccine companies' ability to develop and protect their trade
Can gene-editing help solve the energy crisis?
What role can biofuels play in fighting climate change and can CRISPR sequencing technology help it reach its potential?
